Hyperinsulinemia and risk for hepatocellular carcinoma in patients with chronic liver diseases and Type 2 diabetes mellitus

2009 ◽  
Vol 3 (5) ◽  
pp. 465-467 ◽  
Author(s):  
Valter Donadon ◽  
Massimiliano Balbi ◽  
Giorgio Zanette
Keyword(s):  
Diabetes Mellitus ◽  
Hepatocellular Carcinoma ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Liver Diseases ◽  
Chronic Liver ◽  
Chronic Liver Diseases

scholarly journals Metformin modifies disparity in hepatocellular carcinoma incidence in men with type 2 diabetes but without chronic liver diseases

2019 ◽  
Vol 8 (6) ◽  
pp. 3206-3215 ◽  
Author(s):  
Chen‐Pin Wang ◽  
John Kuhn ◽  
Dimpy P. Shah ◽  
Susanne Schmidt ◽  
Yui‐Wing F. Lam ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Type 2 Diabetes ◽  
Liver Diseases ◽  
Chronic Liver ◽  
Chronic Liver Diseases

scholarly journals Prevalence of type 2 diabetes mellitus in Japanese patients with hepatocellular carcinoma

2010 ◽  
Vol 2 (1) ◽  
pp. 81-84 ◽  
Author(s):  
NAOTA TAURA ◽  
TATSUKI ICHIKAWA ◽  
HISAMITSU MIYAAKI ◽  
HIROSHI YATSUHASHI ◽  
HIROMI ISHIBASHI ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Hepatocellular Carcinoma ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Japanese Patients

Gut microbiota in nonalcoholic fatty liver diseases with and without type-2 diabetes mellitus

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Hamed Ebrahimzadeh Leylabadlo ◽  
Hossein Samadi Kafil ◽  
Safar Farajnia ◽  
Dariush Shanehbandi ◽  
Seyed Yaghoub Moaddab ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Gut Microbiota ◽  
Fatty Liver ◽  
Liver Diseases ◽  
Nonalcoholic Fatty Liver ◽  
Nonalcoholic Fatty Liver Diseases

scholarly journals Type 2 diabetes and risk of hospital admission or death for chronic liver diseases

2016 ◽  
Vol 64 (6) ◽  
pp. 1358-1364 ◽  
Author(s):  
Sarah H. Wild ◽  
Joanne R. Morling ◽  
David A. McAllister ◽  
Jan Kerssens ◽  
Colin Fischbacher ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Hospital Admission ◽  
Liver Diseases ◽  
Chronic Liver ◽  
Chronic Liver Diseases

scholarly journals HbA1c-Based Score Model for Predicting Death Risk in Patients with Hepatocellular Carcinoma and Type 2 Diabetes Mellitus

2017 ◽  
Vol 2017 ◽  
pp. 1-7
Author(s):  
Lingling He ◽  
Shuan Zhang ◽  
Xiaoli Liu ◽  
Yuyong Jiang ◽  
Xianbo Wang ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Hepatocellular Carcinoma ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
High Risk ◽  
Risk Group ◽  
High Risk Group ◽  
Death Risk ◽  
Score Model

Aim. To establish a new score model to predict risk of death in patients with hepatocellular carcinoma and type 2 diabetes mellitus.Methods. This was a retrospective study of 147 patients with hepatocellular carcinoma and type 2 diabetes mellitus who came to Beijing Ditan Hospital between October 2008 and June 2013. Univariate and multivariate logistic regression analysis was performed to obtain the independent factors associated with death risk. A new score model was devised according to these factors.Results. A prediction score model composed of HbA1c, NLR, age, and CTP class was devised, which ranged from 0 to 7. AUROC of the score was 0.853 (P<0.001, 95% CI: 0.791–0.915). Scores 0–2, 3-4, and 5–7 identified patients as low-, medium-, and high-risk categories. The cumulative survival rate was 93.6%, 83.0%, and 74.5% in the low-risk group in 1, 2, and 3 years, while it was 64.0%, 46.0%, and 26.0% in the medium-risk group, whereas it was 24.0%, 12.0%, and 6.0% in the high-risk group, respectively. The cumulative survival rate was significantly higher in the low-risk group than that in the medium-risk group and high-risk group (P<0.001).Conclusion. The HbA1c-based score model can be used to predict death risk in patients with hepatocellular carcinoma and type 2 diabetes mellitus.

Sign in / Sign up

Export Citation Format

Share Document